Finance

Beta
Ask
Lists
002688:SHE
Jinhe Biotechnology Co Ltd
CN¥5.08
+1.60%
(+0.080) 1D
Jun 15, 9:37:18 AM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 002688...
Open
CN¥5.00
High
CN¥5.09
Low
CN¥4.99
Mkt. cap
3.85B
Avg. vol.
12.27M
Volume
1.01M
Dividend
1.97%
Quarterly dividend
CN¥0.03
Ex-dividend date
Jun 1, 2026
P/E ratio
89.04
52-wk high
CN¥8.06
52-wk low
CN¥4.81
EPS
CN¥0.06
Shares outstanding
769.50M
No. of employees
3K
Open
CN¥5.00
High
CN¥5.09
Low
CN¥4.99
Mkt. cap
3.85B
Avg. vol.
12.27M
Volume
1.01M
Dividend
1.97%
Quarterly dividend
CN¥0.03
Ex-dividend date
Jun 1, 2026
P/E ratio
89.04
52-wk high
CN¥8.06
52-wk low
CN¥4.81
EPS
CN¥0.06
Shares outstanding
769.50M
No. of employees
3K
News stories
From sources across the web
About Jinhe Biotechnology Co Ltd
CEO-
Employees2.71K
FoundedMar 14, 1990
Headquarters-
SectorPharmaceutical industry
Previous reportsAll values in CNY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CNY
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
765.11M
645.94M
841.90M
741.88M
Cost of goods sold
507.94M
437.99M
596.11M
477.57M
Cost of revenue
507.94M
437.99M
596.11M
477.57M
Research and development expenses
23.88M
39.13M
30.94M
19.44M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
112.58M
143.79M
126.30M
136.75M
Operating expense
139.23M
171.63M
177.94M
160.24M
Total operating expenses
647.18M
609.61M
774.05M
637.80M
Operating income
117.94M
36.33M
67.85M
104.08M
Other non operating income
-2.58M
-3.52M
2.00M
-6.68M
EBT including unusual items
100.02M
1.12M
-121.60M
76.97M
EBT excluding unusual items
93.24M
12.81M
42.27M
78.17M
Income tax expense
13.86M
4.29M
24.16M
13.63M
Effective tax rate
13.85%
382.50%
-19.87%
17.71%
Other operating expenses
3.54M
-13.29M
18.61M
2.17M
Net income
86.80M
1.15M
-111.51M
62.30M
Net profit margin
11.35%
0.18%
-13.25%
8.40%
Earnings per share
-
-
-
-
Interest and investment income
467.10K
1.28M
5.19M
1.06M
Interest expense
-22.93M
-20.94M
-24.00M
-20.29M
Net interest expenses
-22.46M
-19.66M
-18.80M
-19.22M
Depreciation and amortization charges
-
-
-
-
EBITDA
176.18M
82.63M
125.26M
161.49M
Gain or loss from assets sale
-75.91K
75.91K
2.73M
-
AI content may include mistakes. Learn more
AI content may include mistakes. Learn more